RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Journal Specifications
- PublisherBENTHAM SCIENCE PUBL LTD
- FrequencySemi-annual
- FrequencySemi-annual
- Publisher URL
- Website URL
Recently Published Papers
FAQs
How frequently is the RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY published? 
RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY is published Semi-annual.
Who is the publisher of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?
The publisher of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY is BENTHAM SCIENCE PUBL LTD.
How can I view the journal metrics of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY on editage?
For the RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?
The eISSN number is 2772-2708 and pISSN number is 2772-2716 for RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.